Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Transition of Combivent Respimat is nearly complete as Boehringer Ingelheim plans to cease distribution of Combivent MDI in May.
Breo Ellipta is a novel combination inhaler indicated for the maintenance of COPD, including chronic bronchitis and/or emphysema.
Since April 2012, a novel coronavirus (NCoV) has infected 31 adults in six countries.
For preterm infants, administration of the monoclonal antibody palivizumab for prevention of respiratory syncytial virus (RSV) infection is associated with a significant reduction in the number of days of wheezing during the first year of life.